Cleared Traditional

K030477 - DIADEXUS PLAC TEST (FDA 510(k) Clearance)

Jul 2003
Decision
155d
Days
Class 2
Risk

K030477 is an FDA 510(k) clearance for the DIADEXUS PLAC TEST. This device is classified as a Test, System, Immunoassay, Lipoprotein-associated Phospholipase A2 (Class II - Special Controls, product code NOE).

Submitted by Diadexus, Inc. (South San Francisco, US). The FDA issued a Cleared decision on July 18, 2003, 155 days after receiving the submission on February 13, 2003.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5600. The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, Is Intended To Measure Lipoprotein-associated Phospholipase A2 In Human Plasma In Conjunction With Clinical Evaluation And Other Patient Risk Factors Including Biochemical Analyses As An Aid In Predicting Risk For Coronary Heat Disease. This Device Differs From The Classification Regulation In That It Is A Different Analyte, Thus A New Marker For Predicting Risk Of Coronary Heart Disease. This Device Is Measuring An Enzyme That Is Produced By Macrophages Where As The Regulation Is For The Measurement Of A Lipoprotein..

Submission Details

510(k) Number K030477 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 2003
Decision Date July 18, 2003
Days to Decision 155 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code NOE — Test, System, Immunoassay, Lipoprotein-associated Phospholipase A2
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5600
Definition The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, Is Intended To Measure Lipoprotein-associated Phospholipase A2 In Human Plasma In Conjunction With Clinical Evaluation And Other Patient Risk Factors Including Biochemical Analyses As An Aid In Predicting Risk For Coronary Heat Disease. This Device Differs From The Classification Regulation In That It Is A Different Analyte, Thus A New Marker For Predicting Risk Of Coronary Heart Disease. This Device Is Measuring An Enzyme That Is Produced By Macrophages Where As The Regulation Is For The Measurement Of A Lipoprotein.

Similar Devices — NOE Test, System, Immunoassay, Lipoprotein-associated Phospholipase A2

All 7
Diazyme PLAC® Test for Lp-PLA2 Activity
K203136 · Diazyme Laboratories, Inc. · Aug 2021
PLAC TEST FOR LP-PLA2 ACTIVITY
K141575 · Diadexus, Inc. · Dec 2014
PLAC TEST REAGENT KIT, MODELS 90107, 90112, 90115, 90116, 10-0112, 10-0113, 10-0115
K101853 · Diadexus, Inc. · Jan 2011
PLAC TEST REAGENT KIT,CALIBRATOR KIT, LP-PLA2 CONTROL KIT, MODEL(S) 90107,90109,90109
K072599 · Diadexus, Inc. · Dec 2007
MODIFICATION TO DIADEXUS PLAC TEST
K062234 · Diadexus, Inc. · Sep 2006
DIADEXUS PLAC TEST
K050523 · Diadexus, Inc. · Jun 2005